Product
GenSci048
Aliases
GenSci048 placebo
1 clinical trial
3 indications
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseStatus: Not yet recruiting, Estimated PCD: 2026-03-31